Pharmasciences

For profit

Also known as: Pharma Science | Pharmascience Inc. | PHARMASCIENCE INC

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

Nov 1, 2012

First marketed drug

Jan 19, 2001

Last known activity

Nov 30, 2020

Acquired by Cytokine PharmaSciences → Ferring on Jan 1, 1999

Timeline

1980s

Jan 1, 1983
Pharmasciences— Founded

1990s

Jan 1, 1999
Cytokine PharmaSciences— Acquired By

2010s

May 1, 2011
Aegera Therapeutics— Acquired
Oct 20, 2011
Ferring— Now
Dec 8, 2017
ganciclovir— Marketing Organization

Drugs by trial phase (8 distinct, 12 trials)

Phase 2 (4 own, 4 via acquisition)

Indications

Studied for

Marketed drugs (7)

Subsidiaries (1 direct, 1 total across the full acquisition tree)

Aegera Therapeutics

Recent trials (3)

NCT04536090CollaboratorPhase 2Nov 30, 2020
NCT04046328Lead sponsorPhase 2Sep 30, 2019
NCT01628471Lead sponsorPhase 1/Phase 2Nov 1, 2012

Details

Founded: Montreal, CA Jan 1, 1983
Last known activity: Nov 30, 2020

Notes

--- Pre-folding founded info: 1992-01-01 King of Prussia PA United States http://www.sptimes.com/News/122901/news_pf/State/Foundations__founder_.shtml ---